Tag: Hoau-Yan Wang

Jul 27, 2022. The United States Department of Justice has opened an investigation into the Austin, Texas-based Cassava Sciences regarding allegations that the company falsified data to support Simufilam, its drug candidate for Alzheimer’s disease. The probe could swing both ways, leading to criminal charges or end with no resulting lawsuit. The probe, revealed in an exclusive report by Reuters,…